ADAM17 and familial dilated cardiomyopathy: As a wealth of evidence indicates that RAS is highly activated in DCM19,20, a series of in vivo and in vitro experiments were designed and performed to examine the effect of ADAM17 on the pathogenesis and treatment of DCM.